Advanced Enzyme Technologies has received approval for the acquisition of an additional stake of upto 5.89% of JC Biotech (existing 89.83% subsidiary) by way of purchase of upto 12,18,976 Equity Shares from few existing shareholders of JC Biotech (Transferors) for the total consideration not exceeding Rs 5.60 crore (i.e. upto Rs 46 per share). The Board of Directors of the Company at its Meeting held on February 10, 2024 has approved the same.
The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions.
